RCUS · Arcus Biosciences, Inc.
$29.48
+0.62 (+2.15%)
At close · Aug 14
Market Cap
$3.75B
Shares
127.33M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jennifer Jarrett | Chief Operating Officer | Resigned | 2026-03-23 |
| Dietmar Berger M.D., Ph.D. | Class II director | Appointed | 2025-02-06 |
| Richard Markus, M.D., Ph.D. | Chief Medical Officer | Appointed | 2025-01-21 |
| Jennifer Jarrett | Board | Resigned | 2024-01-30 |
| Johanna Mercier | Class II director | Appointed | 2024-01-30 |
| Juan Jaen | Board | Resigned | 2024-01-30 |
| Alexander Azoy | Principal Accounting Officer | Appointed | 2023-03-10 |
Key facts
CIK
1724521
CUSIP
03969F109
13F (30d)
217 filings
216 filers
Visit website
Investor relations